Impact of plasma tissue inhibitor of metalloproteinase-1 on long-term survival in patients with gastric cancer
Authors:
- 24 April 2009
- journal article
- Published by Springer Nature in Gastric Cancer
- Vol. 12 (1) , 31-36
Abstract
The expression of tissue inhibitor of metalloproteinase-1 (TIMP-1) is correlated with tumor invasion and metastases. The plasma TIMP-1 concentration was examined preoperatively in 149 patients with gastric cancer who underwent a surgical resection. The cutoff value of TIMP-1 was set at 112.5 ng/ml based on a previous report. These patients were followed up for more than 5 years prospectively. Plasma TIMP-1 was positive in 30 of the 149 patients (20.1%). The overall survival rate was 78.2% at 5 years in patients with negative plasma TIMP-1, while this rate was 26.7% at 5 years in patients with positive plasma TIMP-1. By univariate analyses, T, N, M, and R category, and TIMP-1, were significant prognosticators. Multivariate analyses demonstrated T, N, and TIMP-1 to be significant prognosticators. The survival curve was clearly separated with respect to TIMP-1. These results suggest that plasma TIMP-1 is a strong independent prognosticator for the long-term survival of patients with gastric cancer.Keywords
This publication has 27 references indexed in Scilit:
- A Comparative Study of Tissue Inhibitor of Metalloproteinases-1 Levels in Plasma and Tumour Tissue from Patients with Primary Breast Cancer and in Plasma from Patients with Metastatic Breast CancerTumor Biology, 2008
- Impact of Plasma Tissue Inhibitor of Matrix Metalloproteinase-1 on Long-Term Survival in Patients with Colorectal CancerOncology, 2007
- Protein levels of tissue inhibitor of metalloproteinase-1 in tumor extracts as a marker for prognosis and recurrence in patients with gastric cancerGastric Cancer, 2006
- Disparities in Gastric Cancer Chemotherapy Between the East and WestJournal of Clinical Oncology, 2006
- TNM and Japanese staging systems for gastric cancer: how do they coexist?Gastric Cancer, 2004
- Association between preoperative plasma levels of tissue inhibitor of metalloproteinases 1 and rectal cancer patient survivalEuropean Journal of Cancer, 2004
- Serum Levels of Tissue Inhibitor of Metalloproteinases-1 (TIMP-1) in Colorectal Cancer PatientsSurgery Today, 2003
- Surgery for gastric cancer: 10-year experience worldwideGastric Cancer, 2001
- Matrix metalloproteinases and their inhibitors in gastric cancerGut, 1998
- Rapid one-step sandwich enzyme immunoassay for tissue inhibitor of metalloproteinases An application for rheumatoid arthritis serum and plasmaJournal of Immunological Methods, 1990